Purchase Order 75N93025P00972

Award Date 5/15/25
Potential Completion Date 5/14/26
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,092 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for a SERVICE CONTRACT FOR AUTOMACS PRO SEPARATOR with a completion date of December 14, 2020. Miltenyi Biotec, a global biotechnology company, has served as a prime contractor on numerous contracts with federal agencies,...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of biotechnology products and services. The $22,175 contract provides a one-year period of performance for the NIH's National Institute of Allergy and Infectious Diseases to acquire Miltenyi's MACSQuant flow cytometer analyzer and AutoMACS Pro cell separator. These products and associated...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,081.00 firm fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for a GENTLEMACS OCTO DISSOCIATOR WITH HEATERS scientific instrument and associated freight charges. The award does not utilize a set-aside designation. Miltenyi Biotec specializes in providing scientific instruments, bioreagents, and services to...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of goods. The $211,830 contract is for the provision of Miltenyi's biotechnology products and services to support biomedical research and cell and gene therapy, including instruments, reagents, kits, and antibodies. The award does not have a set-aside...
This is a $31,160 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the delivery of a GentleMACS Octo Dissociator with heating units, which are specialized laboratory instruments used for tissue dissociation and cell isolation. The award is not associated with a set-aside program. Miltenyi Biotec, a global biotechnology company,...
The U.S. government agency National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract worth $41,906.00 to Miltenyi Biotec, Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of an Automacs Pro Separator Starter Kit, a specialized scientific instrument used for cell separation and analysis. This award is not associated with a larger contract vehicle. The contract does not have a set-aside designation....
This is a $4,250 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products. The contract is not set aside and runs through May 2011. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables under this award...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $8,347.50 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer. The contract is for the delivery of GentleMACTM Tumor Dissociator Kits, T-Cell Isolation Kits, and related columns. This purchase order is not associated with a set-aside program. Miltenyi Biotec is an experienced federal contractor, having provided specialized laboratory equipment,...
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...
This is a $17,976 firm fixed price purchase order awarded to Miltenyi Biotec, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for laboratory equipment and supplies. The contract is not set aside. Miltenyi Biotec is a global biotechnology company that specializes in cell separation, analysis, and processing technologies. Under this contract, the company will provide a variety of products and services to support biomedical...

This is a $19,325.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is for the provision of specialized scientific equipment and associated maintenance services, including items such as GentleMACS Octo Dissociators, MACSQuant Analyzers, and CliniMACS cell processing systems. This contract is not set aside and represents one of Miltenyi Biotec's many federal contract awards, primarily within the National Institutes of Health ecosystem, where the company is a critical supplier of specialized equipment and reagents supporting advanced biomedical research and cell therapy development. The contract has an ultimate completion date of May 14, 2026.

Generated 5/7/25, 9:56 AM